Prediction of marbofloxacin dosage for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida by pharmacokinetic/pharmacodynamic modelling
Abstract Background Bacterial pneumonia in pigs occurs widely and requires antimicrobial therapy. It is commonly caused by the pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida. Marbofloxacin is an antimicrobial drug of the fluoroquinolone class, licensed for use against these orga...
Main Authors: | Lucy Dorey, Ludovic Pelligand, Peter Lees |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | BMC Veterinary Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12917-017-1128-y |
Similar Items
-
Integrated pharmacokinetic–Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets
by: Qing Lin Zeng, et al.
Published: (2017-06-01) -
Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens
by: Lucy Dorey, et al.
Published: (2017-06-01) -
In vitro and in vivo Synergistic Effects of Florfenicol and Thiamphenicol in Combination Against Swine Actinobacillus pleuropneumoniae and Pasteurella multocida
by: Porjai Rattanapanadda, et al.
Published: (2019-10-01) -
In vivo antimicrobial activity of marbofloxacin against Pasteurella multocida in a tissue cage model in calves
by: Changfu eCao, et al.
Published: (2015-07-01) -
Pharmacokinetic/pharmacodynamic integration and modelling of florfenicol for the pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
by: Lucy Dorey, et al.
Published: (2017-01-01)